1-5 of 5
Peter D. Cole
Close
Sort by
Journal Articles

Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score–matched analysis

Clinical Trials & Observations
Julia Driessen, Fer de Wit, Alex F. Herrera, Pier Luigi Zinzani, Ann S. LaCasce, Peter D. Cole, Craig H. Moskowitz, Ramón García-Sanz, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée M. Zijlstra, Barbara A. Hutten, Alison J. Moskowitz, Marie José Kersten
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2740–2752.
https://doi.org/10.1182/bloodadvances.2023012145
Published: 2024
Includes: Supplemental data
Journal Articles

Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001

Clinical Trials & Observations
Thai Hoa Tran, Sylvie Langlois, Caroline Meloche, Maxime Caron, Pascal Saint-Onge, Alexandre Rouette, Alain R. Bataille, Camille Jimenez-Cortes, Thomas Sontag, Henrique Bittencourt, Caroline Laverdière, Vincent-Philippe Lavallée, Jean-Marie Leclerc, Peter D. Cole, Lisa M. Gennarini, Justine M. Kahn, Kara M. Kelly, Bruno Michon, Raoul Santiago, Kristen E. Stevenson, Jennifer J. G. Welch, Kaitlin M. Schroeder, Victoria Koch, Sonia Cellot, Lewis B. Silverman, Daniel Sinnett
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1329–1341.
https://doi.org/10.1182/bloodadvances.2021005634
Published: 2022
Includes: Supplemental data
Journal Articles

Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohort

Clinical Trials & Observations
Song Yao, Qianqian Zhu, Peter D. Cole, Kristen Stevenson, Marian H. Harris, Emily Schultz, Justine M. Kahn, Elena J. Ladas, Uma H. Athale, Luis A. Clavell, Caroline Laverdiere, Jean-Marie Leclerc, Bruno Michon, Marshall A. Schorin, Jennifer J. G. Welch, Stephen E. Sallan, Lewis B. Silverman, Kara M. Kelly
Journal: Blood Advances
Blood Adv (2021) 5 (2): 451–458.
https://doi.org/10.1182/bloodadvances.2020003060
Published: 2021
Includes: Supplemental data
Journal Articles

Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001

Clinical Trials & Observations
Lynda M. Vrooman, Traci M. Blonquist, Marian H. Harris, Kristen E. Stevenson, Andrew E. Place, Sarah K. Hunt, Jane E. O’Brien, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdiere, Jean-Marie Leclerc, Bruno Michon, Marshall A. Schorin, Maria Luisa Sulis, Jennifer J. G. Welch, Donna S. Neuberg, Stephen E. Sallan, Lewis B. Silverman
Journal: Blood Advances
Blood Adv (2018) 2 (12): 1449–1458.
https://doi.org/10.1182/bloodadvances.2018016584
Published: 2018
Includes: Supplemental data
Journal Articles

Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia

Clinical Trials & Observations
Thai Hoa Tran, Marian H. Harris, Jonathan V. Nguyen, Traci M. Blonquist, Kristen E. Stevenson, Eileen Stonerock, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdiere, Jean-Marie Leclerc, Bruno Michon, Marshall A. Schorin, Jennifer J. G. Welch, Shalini C. Reshmi, Donna S. Neuberg, Stephen E. Sallan, Mignon L. Loh, Lewis B. Silverman
Journal: Blood Advances
Blood Adv (2018) 2 (5): 529–533.
https://doi.org/10.1182/bloodadvances.2017014704
Published: 2018